CIK 0001863127
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Tyra Biosciences, Inc.
Sign in to watch- Ticker
- TYRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831476348
- Phone
- +1 619-728-4760
- Business address
- 2656 STATE STREET, CARLSBAD, CA, 92008
- Open-market buys, last 90 days
- $20,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | KAPLAN GILLA Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2023-05-31 | Verjee Rehan Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2023-05-31 | Simson Jake Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2023-05-31 | Subramony Siddarth Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2023-05-31 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2023-05-31 | Kjellson Nina S Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2023-05-31 | CHEN ISAN Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2023-05-31 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +14,500 | 14,500 | ||
| 2023-04-03 | Harris Todd Chief Executive Officer | Option exercise 10b5-1 | +2,000 | $2.25 | $5K | 1,703,276 |
| 2023-04-03 | Harris Todd Chief Executive Officer | Sale 10b5-1 | −2,000 | $16.13 | $32K | 1,701,276 |
| 2023-04-03 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 397,537 | ||
| 2023-04-03 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +2,000 | $0.61 | $1K | 529,981 |
| 2023-04-03 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −2,000 | $16.16 | $32K | 527,981 |
| 2023-04-03 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 229,421 | ||
| 2023-03-31 | Bensen Daniel Chief Operating Officer | Option exercise 10b5-1 | +400 | $0.61 | $244 | 528,381 |
| 2023-03-31 | Bensen Daniel Chief Operating Officer | Sale 10b5-1 | −400 | $16.00 | $6K | 527,981 |
| 2023-03-31 | Bensen Daniel Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −400 | 231,421 | ||
| 2023-03-31 | Harris Todd Chief Executive Officer | Option exercise | +500 | $2.25 | $1K | 1,701,776 |
| 2023-03-31 | Harris Todd Chief Executive Officer | Sale | −500 | $16.05 | $8K | 1,701,276 |
| 2023-03-31 | Harris Todd Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −500 | 399,537 |
Page 13 of 21 · 417 trades